Similar articles

• Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.

  Lee LA. Lee LA. Arch Dermatol. 1988 Jan;124(1):61-2. Arch Dermatol. 1988. PMID: 3257370 No abstract available.
• Candidate T cell epitopes of the human La/SSB autoantigen.

  Davies ML, Taylor EJ, Gordon C, Young SP, Welsh K, Bunce M, Wordsworth BP, Davidson B, Bowman SJ. Davies ML, et al. Arthritis Rheum. 2002 Jan;46(1):209-14. doi: 10.1002/1529-0131(200201)46:1<209::AID-ART10066>3.0.CO;2-1. Arthritis Rheum. 2002. PMID: 11817592
• The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.

  Alexander EL, McNicholl J, Watson RM, Bias W, Reichlin M, Provost TT. Alexander EL, et al. J Invest Dermatol. 1989 Dec;93(6):751-6. doi: 10.1111/1523-1747.ep12284404. J Invest Dermatol. 1989. PMID: 2584740
• Molecular definition of the Ro(SSA) particle(s): a frequent target of autoimmunity in systemic lupus erythematosus and Sjögren's syndrome.

  Reichlin M. Reichlin M. Br J Rheumatol. 1991;30 Suppl 1:58-62. Br J Rheumatol. 1991. PMID: 1991243 Review. No abstract available.
• Sjögren syndrome and systemic lupus erythematosus are distinct conditions.

  Scheinfeld N. Scheinfeld N. Dermatol Online J. 2006 Jan 27;12(1):4. Dermatol Online J. 2006. PMID: 16638372 Review.